Aortic Stenosis with High Gradients and Area >1: Just Follow Up?

Definig severe aortic stenosis (AS) rests upon Doppler parameters, and uses log-established cutoff values, which include peak velocity (PV) ≥ 4 m/s, mean gradient (MG) ≥ 40 mmHg and aortic valve area (AVA) ≤ 1 cm². However, there are value discrepancies in up to 30-40% of cases, which has given way to different clinical profiles. 

angulación aórtica post TAVR

One of the discrepant phenotypes corresponds to patients with high gradients (HG) and AVA > 1 cm². Their management and prognosis has hardly been approached by clinical guidelines. The aim of this study was to look into the clinical and hemodynamic characteristics of this group and compare their mortality against other AS subtypes. 

This was a retrospective study on echocardiographic data from the Mayo Clinic (Minnesota, EE. UU.). It included patients with AS diagnosis classified according to AVA, PV and MG into four groups. Patients with prior valve surgery, left ventricular outflow tract obstruction, mitral or aortic insufficiency or mitral stenosis were excluded. Primary outcome was all cause mortality. 

Data from 3,209 were collected, distributed by hemodynamic characteristics as follows: 7.2% phenotype AG-AVA > 1, 45.9% phenotype HG-AVA ≤ 1, 14.3% low gradient phenotype with AVA ≤ 1 (LG-AVA ≤ 1), and 32.6% moderate AS.

HG-AVA > 1 patient mean age was 70.2 ± 12 years, making this the youngest of subtypes (P < 0.01), also presenting higher prevalence of male sex (85.7%), larger body surface and body mass index (BMI), and higher incidence of bicuspid aortic valve (39.6%). They had fewer comorbidities and lower levels of natriuretic peptide type B (BNP). PV and MG values were lower vs. phenotype AVA ≤ 1 (P < 0.01), while 115.0 ± 19 mL systolic volume (SV) and 54.8 ± 10.5 mL/m² indexed value (SV index) were higher.

Read also: SCAAR Registry: Coronary Angioplasty in Venous Grafts.

During a 944-day followup, there were 1,523 deaths (47.5%). Phenotype HG-AVA > 1 presented 38.9% mortality rate at 5 years, and 59.6% at 8 years. After adjusting for age, mortality in this group resulted similar to that of moderate AS patients, but lower vs. phenotype LG-AVA ≤ 1 (HR: 1.9 [CI 95%: 1.4-2.4]; P < 0.01).

As regards aortic valve replacement (AVR), mainly surgical (12.9% were TAVR), 67.4% of patients with HG-AVA > 1 were treated, vs. 69% of HG-AVA ≤ 1, 32.8% of LG-AVA ≤ 1 and 34.7% of moderate AS patients. Mortality in AVR patients, resulted higher in patients with AVA ≤ 1, both for HG (HR: 1.5 [CI 95%: 1.1-2.0]; P = 0.03) and LG patients (HR: 2.4 [CI 95%: 1.6-3.5]; P < 0.001).

Mortality rate for patients with HG-AVA > 1 undergoing AVR was superior to that of one controlled matched population, but significantly lower to that of HG-AVA > 1 patients not operated on (mortality rate 8.2 [CI 95%: 5.9-11.2]).

Conclusions

In this cohort of patients with AS, individuals with high gradients and > 1 cm² valve area were characterized for being younger, and have lower comorbidities vs. other phenotypes. Presented higher survival, expect for a matched population. Aortic valve replacement showed an 8-year survival benefit vs. the non-treated, which suggests a positive impact of surgery for this specific group. 

Original Title: High-Gradient Aortic Stenosis With Valve Area >1.0 cm2 The “Forgotten” Discordant Hemodynamic Phenotype.

Reference: Ito S, Oh JK, Michelena HI, Egbe AC, Connolly HM, Pellikka PA, Nkomo VT, Lewis BR, Miranda WR. High-Gradient Aortic Stenosis With Valve Area >1.0 cm2: The “Forgotten” Discordant Hemodynamic Phenotype. JACC Cardiovasc Imaging. 2024 Sep 5:S1936-878X(24)00315-2. doi: 10.1016/j.jcmg.2024.07.025. Epub ahead of print. PMID: 39297851.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

Hemodynamic Outcomes of Edge-to-Edge Repair in Degenerative and Functional Mitral Regurgitation

Transcatheter edge-to-edge mitral valve repair (M-TEER) has become an established therapeutic option for mitral valve disease. Among the available techniques, M-TEER using the MitraClip...

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Inflammation after TAVI: An Emerging Therapeutic Target?

Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...

Dual-Prep Registry: Atherectomy and IVL for Severe Coronary Calcification

Severe coronary calcification remains one of the most challenging scenarios in percutaneous coronary intervention (PCI). Although rotational or orbital atherectomy and intravascular lithotripsy (IVL)...

Hemodynamic Outcomes of Edge-to-Edge Repair in Degenerative and Functional Mitral Regurgitation

Transcatheter edge-to-edge mitral valve repair (M-TEER) has become an established therapeutic option for mitral valve disease. Among the available techniques, M-TEER using the MitraClip...